| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048684540 |
| P356 | DOI | 10.1038/AJG.2012.7 |
| P698 | PubMed publication ID | 22290404 |
| P5875 | ResearchGate publication ID | 221791833 |
| P2093 | author name string | Paul Martin | |
| Andres F Carrion | |||
| P2860 | cites work | The prevalence of hepatitis B virus infection in the United States in the era of vaccination | Q45375431 |
| Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. | Q45388033 | ||
| Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease | Q45393741 | ||
| Hepatitis C virus infection in a resident elderly population: a 10-year follow-up study. | Q45417459 | ||
| Hepatitis A virus infection in the United States: serologic results from the Third National Health and Nutrition Examination Survey | Q45422212 | ||
| Hepatitis B virus infection among residents of a nursing home for the elderly: seroepidemiological study and molecular evolutionary analysis | Q45739744 | ||
| Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors | Q45739971 | ||
| High carrier rate after hepatitis B virus infection in the elderly | Q45774487 | ||
| Predicting cirrhosis risk based on the level of circulating hepatitis B viral load | Q46985831 | ||
| Incidence of hepatitis A in the United States in the era of vaccination | Q47263400 | ||
| Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly | Q50114310 | ||
| Hepatitis C: Should antiviral therapy be offered to elderly patients? | Q50561889 | ||
| Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C. | Q50571426 | ||
| Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? | Q50576728 | ||
| Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C. | Q50577281 | ||
| Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. | Q51144962 | ||
| The influence of donor age on liver regeneration and hepatic progenitor cell populations. | Q53236649 | ||
| HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma. | Q53468576 | ||
| The effect of age upon liver volume and apparent liver blood flow in healthy man. | Q53846028 | ||
| Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials | Q24683341 | ||
| Aging and immune function: molecular mechanisms to interventions | Q28387056 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| Telaprevir for retreatment of HCV infection | Q29619799 | ||
| Telaprevir for previously untreated chronic hepatitis C virus infection | Q29619800 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Boceprevir for untreated chronic HCV genotype 1 infection | Q29620617 | ||
| Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion | Q33945490 | ||
| Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries | Q33945888 | ||
| EASL Clinical Practice Guidelines: management of hepatitis C virus infection | Q34168383 | ||
| Hepatitis C in the elderly: epidemiology, natural history, and treatment | Q34178971 | ||
| Liver disease in the elderly | Q34296580 | ||
| An outbreak of hepatitis A associated with green onions. | Q34447483 | ||
| Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 | ||
| Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? | Q34537738 | ||
| Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir. | Q34601513 | ||
| Parenchymal liver disease in the elderly | Q35841194 | ||
| Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy | Q36379054 | ||
| Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease | Q36570811 | ||
| Hepatitis A vaccines and the elderly | Q36650880 | ||
| Chronic hepatitis B: current epidemiology in the Americas and implications for management. | Q36655273 | ||
| Two years' investigation of epidemic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia | Q36692873 | ||
| Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury | Q36845686 | ||
| Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies. | Q37275962 | ||
| Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994 | Q37389167 | ||
| Serious hepatitis A: an analysis of patients hospitalized during an urban epidemic in the United States | Q39459122 | ||
| The healthcare burden imposed by liver disease in aging Baby Boomers | Q39878799 | ||
| Viral hepatitis in older adults | Q41495778 | ||
| Hepatitis C virus infection in the elderly | Q42978028 | ||
| Seroprevalence of viral hepatitis in an older nursing home population | Q42995196 | ||
| Risk factors and prevalence of hepatitis E in German immigrants from the former soviet union | Q43038367 | ||
| Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death | Q43180169 | ||
| Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. | Q43659671 | ||
| HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. | Q43686041 | ||
| Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. | Q44010419 | ||
| Hepatitis B e antigen and the risk of hepatocellular carcinoma | Q44068676 | ||
| Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma | Q44458159 | ||
| Which patients with chronic hepatitis B are more likely to relapse after interferon alpha-induced hepatitis B e antigen loss in Korea? | Q44743681 | ||
| Prevalence of HBV precore/core promoter variants in the United States | Q44750050 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | viral hepatitis | Q1983841 |
| P304 | page(s) | 691-697 | |
| P577 | publication date | 2012-01-31 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Viral hepatitis in the elderly | |
| P478 | volume | 107 |
| Q42260138 | Acute hepatitis B outbreaks in 2 skilled nursing facilities and possible sources of transmission: North Carolina, 2009-2010. |
| Q36906779 | Barriers to Treatment Among New York City Residents with Chronic Hepatitis C Virus Infection, 2014 |
| Q26799527 | Dissecting the indirect effects caused by vaccines into the basic elements |
| Q33759883 | Hepatitis A virus infections and outbreaks in asylum seekers arriving to Germany, September 2015 to March 2016. |
| Q59329120 | Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany |
| Q38344214 | Hepatitis B and elders: An underestimated issue |
| Q40498995 | Hospitalization and mortality due to hepatitis A in Taiwan: a 15-year nationwide cohort study |
| Q40391710 | Lack of Any Relationship Between Circulating Autoantibodies and Interleukin–6 Levels in Egyptian Patients Infected with the Hepatitis C Virus |
| Q36043480 | Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in Ghana |
| Q39204755 | Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy |
| Q37204909 | Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States |
Search more.